CD
Charles A. Deignan
Chief Financial Officer

Charles A. Deignan insider trades: Clearside Biomedical (CLSD) stock buys and sales

Chief Financial Officer, Clearside Biomedical Last trade Jan 19, 2024 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2016
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Charles reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 19, 2024CLSD↓ Sell$17K
Jan 19, 2023CLSD↓ Sell$21K
Jan 19, 2022CLSD↓ Sell$18K
Sep 21, 2021CLSD↓ Sell$18K
Jun 21, 2021CLSD↓ Sell$13K
Jun 1, 2020CLSD↓ Sell$28K
Nov 12, 2019CLSD↑ Buy$9K
Mar 15, 2019CLSD↑ Buy$14K
Mar 23, 2018CLSD↑ Buy$6K
Aug 14, 2017CLSD↑ Buy$7K
Jun 7, 2016CLSD↓ Sell$14

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Charles A. Deignan's insider trades

Charles A. Deignan is Chief Financial Officer at Clearside Biomedical (CLSD). Since Jun 7, 2016, Charles has reported 4 open-market purchases worth $35K and 7 sales worth $115K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (14 filings), option exercises (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLSD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.